Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
A 2025 systematic review mapped weight change after stopping anti-obesity medicines across 11 RCTs
Importantly, dulaglutide showed reduced major adverse cardiovascular events (MACE) in the REWIND trial, making it another GLP-1 RA with proven cardiovascular benefit
GLP-1 medications have exploded in popularity over the past few years, and its easy to see why
The choice of alternative therapy depends on individual patient factors including renal function, cardiovascular risk profile, weight management goals, hypoglycaemia risk, and patient preferences, all of which should be discussed thoroughly with the GP or diabetes specialist team
According to Chloe Thomas, PT and founder of Chloe Inspires Coaching, your hips, spine and legs are the areas most at risk for bone loss
In the study, GLP-1 drugs were also linked to a lower risk of addiction disorders
US$ 26.21
US$ 20.40
US$ 29.52
US$ 24.49
US$ 29.04
US$ 26.10
